|
Leadership and Team membersChair: Claudia Ctortecka, Ph.D Northwestern University Evanston, IL, USA Co-chair: Erwin M. Schoof, PhD DTU Bioengineering, Lyngby, Denmark Initiative members: Bogdan Budnik, Ph.D Wyss Institute, Harvard University, USA Zhen Dong, Ph.D Westlake University, Hangzhou, China Ryan Kelly, Ph.D Brigham Young University, Provo, Utah, USA Research Institute of Molecular Pathology, Vienna, Austria Akos Vegvari, Ph.D Medical Biochemistry and Biophysics, Karolinska Institutet, Sweden Roman Zubarev, Ph.D Medical Biochemistry and Biophysics, Karolinska Institutet, Sweden | Why Single Cell Proteomics? Continued developments in SCP will be critical for refining our understanding of cellular function and heterogeneity, ultimately advancing applications in biomedical research and precision medicine. Current lines of work: Since our launch in 2022, the main goal of the Single-Cell Initiative under the Biology and Disease-Driven Human Proteome Project is to foster the development, standardization, and dissemination of applied SCP methods and technologies. The initiative aims to facilitate knowledge exchange and resources between established and newly interested SCP researchers. We organize and contribute to regular webinars, workshops, and symposia to showcase the latest advances, and challenges in SCP. For upcoming events, please check back here regularly.. Initiative membership: Please contact members of the committee directly for further information on how to connect and get involved in SCI |